Zhang, H., Zhang, H., Du, X., Deng, M., Zheng, L., Yao, D., . . . Wu, S. (2022, August). Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option. Frontiers in Pharmacology.
Chicago Style (17th ed.) CitationZhang, Hong-Hong, Hong-Hong Zhang, Xiao-Jing Du, Mei-Ling Deng, Lie Zheng, Dun-Chen Yao, Zhi-Qiang Wang, Qun-Ying Yang, and Shao-Xiong Wu. "Apatinib for Recurrent/progressive Glioblastoma Multiforme: A Salvage Option." Frontiers in Pharmacology Aug. 2022.
MLA (9th ed.) CitationZhang, Hong-Hong, et al. "Apatinib for Recurrent/progressive Glioblastoma Multiforme: A Salvage Option." Frontiers in Pharmacology, Aug. 2022.
Warning: These citations may not always be 100% accurate.
